SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-034692
Filing Date
2024-03-21
Accepted
2024-03-21 16:10:43
Documents
75
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bolt-20231231.htm   iXBRL 10-K 2778459
2 EX-23.1 bolt-ex23_1.htm EX-23.1 2481
3 EX-31.1 bolt-ex31_1.htm EX-31.1 12996
4 EX-31.2 bolt-ex31_2.htm EX-31.2 12704
5 EX-32.1 bolt-ex32_1.htm EX-32.1 6520
6 EX-32.2 bolt-ex32_2.htm EX-32.2 7529
7 EX-97.1 bolt-ex97_1.htm EX-97.1 51852
  Complete submission text file 0000950170-24-034692.txt   10381901

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20231231.xsd EX-101.SCH 1318705
78 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20231231_htm.xml XML 1866609
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39988 | Film No.: 24771437
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)